Positions for Utah Medical Products Inc (NASDAQ:UTMD)

In 2018 Q4 Utah Medical Products Inc (NASDAQ:UTMD) big money sentiment decreased to 1.29, according to SEC filings. So its down -0.63, from 2018Q3’s 1.92. 45 funds started new and increased positions, while 35 cut down and sold holdings in Utah Medical Products Inc so the sentiment has worsened. These funds own 2.66 million shares, that’s down from 2.67 million shares in 2018Q3. Funds holding Utah Medical Products Inc in top 10 was flat from 0 to 0 for the same number . In total 11 funds closed positions, 24 reduced and 29 increased. Also 16 funds bought new Utah Medical Products Inc stakes.

Significant Utah Medical Products Inc Investors

Clean Yield Group owns 28,270 shares in Utah Medical Products Inc as of 2018 Q4. As of 2018 Q4, 58,533 shares of Utah Medical Products Inc are owned by Thomson Horstmann & Bryant Inc. Morgan Dempsey Capital Management Llc reported 12,040 shares. The Texas-based fund Ranger Investment Management L.P. have invested about 0.34% of the institutional investor’s stock portfolio in Utah Medical Products Inc. The Us-based fund Ancora Advisors Llc looks positive on Utah Medical Products Inc, having 75,482 shares.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide.The company has $315.60 million market cap. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.The P/E ratio is 17.13. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

UTMD is touching $84.78 during the last trading session, after increased 0.95%.Utah Medical Products, Inc. has 13,656 shares volume, 24.45% up from normal. UTMD is uptrending and has moved 0.29% since March 27, 2018. The stock underperformed the S&P 500 by 4.08%.

Tower Cap Ltd Co (Trc) owns 326 shs. Penobscot Inv Mgmt owns 4,000 shs. The New York-based Citigroup has invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). Tiaa Cref Inv Management Limited Com owns 7,028 shs or 0% of their US capital. Cwm holds 0% in Utah Medical Products, Inc. (NASDAQ:UTMD) or 9 shs. Fincl Bank Of Montreal Can has invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). Ranger Inv Mgmt Limited Partnership holds 0.34% or 49,816 shs. 3,577 are owned by Cambridge Invest Research Advsr. Aqr Capital Ltd Com holds 0% or 22,071 shs in its capital. Everett Harris And Ca holds 0.01% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD) for 3,080 shs. Marshall Wace Limited Liability Partnership holds 9,334 shs or 0.01% of its capital. Strs Ohio invested in 6,800 shs. 20 were reported by Denali Advsr Limited Liability Corporation. Us State Bank De holds 0% or 10,466 shs in its capital. Moreover, Janney Montgomery Scott Limited Liability Corp has 0% invested in Utah Medical Products, Inc. (NASDAQ:UTMD).

Utah Medical Products, Inc. registered $330,923 net activity with 0 buys and 2 selling transactions since November 27, 2018.

For more Utah Medical Products, Inc. (NASDAQ:UTMD) news posted recently go to: Seekingalpha.com, Nasdaq.com, Globenewswire.com, Investingnews.com or Globenewswire.com. The titles are as follows: “23 Upcoming Dividend Increases – Seeking Alpha” posted on December 06, 2018, “Utah Medical Products, Inc. (UTMD) Ex-Dividend Date Scheduled for March 14, 2019 – Nasdaq” on March 13, 2019, “Utah Medical Products, Inc. Announces Quarterly Dividend – GlobeNewswire” with a publish date: May 08, 2018, “5 Top NASDAQ Medical Device Stocks Year-to-Date | INN – Investing News Network” and the last “Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2018 – GlobeNewswire” with publication date: October 23, 2018.